Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-Glycoprotein Activity Using the Geneva Cocktail Approach
Authors:
- Hengameh GhasimHGHengameh Ghasim
- Mohammadreza RouiniMohammadreza Rouini
- Saeed SafariSSSaeed Safari
- Farnoosh LartiFLFarnoosh Larti
- Mohammadreza KhoshayandMKMohammadreza Khoshayand
- Kheirollah GholamiKGKheirollah Gholami
- Navid NeyshaburinezhadNNNavid Neyshaburinezhad
- Yvonne GloorYGYvonne Gloor
- Youssef DaaliYoussef Daali
- Yalda H. ArdakaniYAYalda H. Ardakani
Open Access
- 25 June 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (7) , 1042
Abstract
The inter-individual variability of CYP450s enzyme activity may be reduced by comparing the effects of bariatric surgery on CYP-mediated drug elimination in comparable patients before and after surgery. The current research will use a low-dose phenotyping cocktail to simultaneously evaluate the activities of six CYP isoforms and P-gp. The results showed that following weight reduction after surgery, the activity of all enzymes increased compared to the obese period, which was statistically significant in the case of CYP3A, CYP2B6, CYP2C9, and CYP1A2. Furthermore, the activity of P-gp after surgery decreased without reaching a statistical significance (p-value > 0.05). Obese individuals had decreased CYP3A and CYP2D6 activity compared with the control group, although only CYP3A was statistically important. In addition, there was a trend toward increased activity for CYP1A2, CYP2B6, CYP2C9, and CYP2C19 in obese patients compared to the control group, without reaching statistical insignificance (p-value ≥ 0.05). After six months (at least), all enzymes and the P-gp pump activity were significantly higher than the control group except for CYP2D6. Ultimately, a greater comprehension of phenoconversion can aid in altering the patient’s treatment. Further studies are required to confirm the changes in the metabolic ratios of probes after bariatric surgery to demonstrate the findings’ clinical application. As a result, the effects of inflammation-induced phenoconversion on medication metabolism may differ greatly across persons and drug CYP pathways. It is essential to apply these results to the clinic to recommend dose adjustments.Keywords
All Related Versions
Funding Information
- National Institute for Medical Research and Development of Iran (NIMAD) (982841)
This publication has 41 references indexed in Scilit:
- Addressing phenoconversion: the Achilles' heel of personalized medicineBritish Journal of Clinical Pharmacology, 2015
- Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood SpotsClinical Pharmacology & Therapeutics, 2014
- The Basel Cocktail for Simultaneous Phenotyping of Human Cytochrome P450 Isoforms in Plasma, Saliva and Dried Blood SpotsClinical Pharmacokinetics, 2014
- Simultaneous LC–MS/MS Quantification of P-Glycoprotein and Cytochrome P450 Probe Substrates and Their Metabolites in DBS and PlasmaBioanalysis, 2014
- Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized TherapyPLOS ONE, 2013
- Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass RecipientsAnnals of Surgery, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Applications of CYP450 Testing in the Clinical SettingMolecular Diagnosis & Therapy, 2013
- The effects of gastric bypass surgery on drug absorption and pharmacokineticsExpert Opinion on Drug Metabolism & Toxicology, 2012
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007